Diagnóstico de Infecções em Pacientes com Neoplasias
DOI:
https://doi.org/10.32635/2176-9745.RBC.1986v32n3.3275Keywords:
Diagnosis, Infection, Immunosuppreed Patient, NeoplasiaAbstract
In the immunocompromised patient the onset of fever should immediately trigger an exhaustive evaluation to determine its etiology. This paper suggests an orderly approach to differential diagnosis whereby the most likely causes of signs or symptoms referable to an organ system or a physical finding are most expeditiously considered and then ruled in or out.
Downloads
References
Johanson WG, Pierce AK, Sanford JP: Changing pharyngeal bacterial flora of hospitalized patients. Emergen of gram-negative bacilli. N. Engi. J. Mcd. 1969. 281: 1137, 1142. DOI: https://doi.org/10.1056/NEJM196911202812101
Meyer DV, Winston D, Young LS et al. Surveillance cultures in immunosuppresd patients. Curr. Chemother. Infect. Dis. 1980, pg 1436.
Schwartz SN, Dowling JN, Benkovik C, et al. Sources of gram-negative bacilli colonizing the trachea of intubated patients. J. Infect. Dis 1978. 138: 227-233. DOI: https://doi.org/10.1093/infdis/138.2.227
Bermudez LE, Panza M, Velasco E Vidal E. Efeito da anti-bioticoterapia sistêmica sobre a flora microbiaria do aparelho gastro-intestinal do paciente hematológico. Rev. Paulista Med. 1984. 102: 256-259.
Hahn DM, Schimpff 5C, Fortner SL Infection in acute Ieukemia patients receiving oral non-absorbable anti biotics. Antimicrob. Agents Chemother. 1978. 13:958-962. DOI: https://doi.org/10.1128/AAC.13.6.958
Bodey GP, Buckley M, Satie 'iS, et ai. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann. Intern. Mcd. 1966. 64: 328-340. DOI: https://doi.org/10.7326/0003-4819-64-2-328
Bermudez LE, Vidal E, Panza M, Velasco E, Nascimento MC, Medeiros Vez AM. Controle de infecção hospitalar: Experiência de dois anos. Rev. Bras. Cancerol. 1984. 30: 6-13. DOI: https://doi.org/10.32635/2176-9745.RBC.1984v30n2.3374
Young LS. Nosocomial infection in the immunocompromised adult. Am. J. Med. 1981. 70: 398-341. DOI: https://doi.org/10.1016/0002-9343(81)90779-8
Bodey GP. Epidemiological studies of Pseudomonas sepsis in patients with ieukemia. Am. J. Med. Scien. 1970. 260: 82-87. DOI: https://doi.org/10.1097/00000441-197008000-00002
Gurwith MJ, Bruton JL, Lank BA, et al. Granulocytopenia in hospitalized patients. I - Prognostic factors and etiology of fever. Am. J. Med. 1978. 64: 121-126. DOI: https://doi.org/10.1016/0002-9343(78)90187-0
Zinner SH for the EORTC International Antimicrobial Therapy Project Group: Review of amikacin usage in the EORTC trials. Am. J. Med. 1985.79 (Suppl lA): 17-20. DOI: https://doi.org/10.1016/0002-9343(85)90186-X
Armstrong D, Young LS, Meyer RD et al. Infectious complications of neoplastic diseases. Med. Clin. North Am. 1971. 55: 729-742. DOI: https://doi.org/10.1016/S0025-7125(16)32514-7
Bermudez LE. Bcteremia em pacientes imunoccuprimidos. Rev. Paulista Med. 1986. 104: 87-92.
Schimpff SC, Young VM. Epidemiology and prevention of infection in the compromised host. in Rubin R.H. and Young L.S. (eds): Clinical Approach to infection in the compromised host. Plenum Publishing, New York, 1981, pg 5-34.
Rubin R.H. The cancer patients with fever and pulmonar infiltrates; Etiology and diagnostic approach. In Remington J.S. and Swartz M.N. (eds), Current Clinical Topics in infections Diseases vol. 1, New York, McGraw-Hill, 1980, pg 288-303.
Mathay RA, Farmer WC, Odero D. Diagnostic fiberoptic broncoscopy in the immunocompromised host with pulmonary infiltrates. Thorax 1977. 32: 539-544. DOI: https://doi.org/10.1136/thx.32.5.539
Wimberiey N, Faling LJ, Bartiett JG. A fiberoptic broncoscopy technique to obtain incontaminated lower airway secretions for bacteriel culture. Am. Rev. Resp. Dis. 1979. 119: 337-342.
Stover D, Zaman A, Hajdu S, Lenga H. Goid J, Armstrong D. Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host. Ann. Intern. Med. 1984. 101: 1-7. DOI: https://doi.org/10.7326/0003-4819-101-1-1
Bodey G.P, Fainstein V. infections of the gastrointestinal tract in the immunocompromised patient. Ann. Rev. Med. 1986. 37: 271-281. DOI: https://doi.org/10.1146/annurev.me.37.020186.001415
Kaptan MH, Armstrong O, Rosen P. Tuberculosis complicating neopiastic disease: A review of 201 cases. Cancer 1974. 33: 850-859. DOI: https://doi.org/10.1002/1097-0142(197403)33:3<850::AID-CNCR2820330334>3.0.CO;2-H
Feld R, Bodey GP, Groschel D. Mycobacteriosis in patients with malignant diseases. Arch. Intern, Med. 1976. 136: 67-74. DOI: https://doi.org/10.1001/archinte.1976.03630010051009
Sharma SD, Remington JS. The role of cell-mediated immunity in resistance to infection in the immunocompromised host. In Infections in Immunocompromised host - Pathogenesis, Prevention and Therapy; J. Verhoef et al. (ed), Elsevier, New York, 1980, pg 59-73.
Kiehn TE, Wong B, Edwards FF, Armstrong D. Comparative recovery of bacteria and yeasts from lysis centrifugation and a conventional blood cuiture system. J. Clin. Microbiol 1983. 18: 300-304. DOI: https://doi.org/10.1128/jcm.18.2.300-304.1983
Cheson BD, Piass RR, Rothstein G. Defective opsonization in muitiple myeloma. Biood 1980. 55: 602-606. DOI: https://doi.org/10.1182/blood.V55.4.602.602
Johnson JE. Celi-mediated immunity - acquired deficiency states. In Waidman RH (cd); Clinical Concepts in immunology. Willians&Wilkins, Baltimore, 1979, pg 24-38.
Wade JC, Schimpff SC, Newman KA, Wiernik PH. Staphy lococcus epidermidis: An increasing cause of infection ir granulocytopenic patients. Ann. Intern. Med. 1982. 97 503-508, 1982. DOI: https://doi.org/10.7326/0003-4819-97-4-503
